Navellier & Associates’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Navellier & Associates’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-5,450	Closed	-$942K	–	407
2015 Q1	$942K	Sell	5,450 -6,691	-55%	-$982K	0.09%	120
2014 Q4	$1.4M	Sell	12,141 -240,487	-95%	-$29.1M	0.07%	86
2014 Q3	$39.5M	Buy	252,628 +211,398	+513%	+$30.6M	1.98%	25
2014 Q2	$5.09M	Sell	41,230 -5,747	-12%	-$635K	0.23%	38
2014 Q1	$4.87M	Buy	+46,977	New	+$4.81M	0.23%	40

Other funds holding SLXP

MMG

Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

Navellier & Associates's SLXP Position: Q2 2015 in Review

Navellier & Associates sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 5,450 shares — an estimated $942K sold.

Navellier & Associates first reported a position in SLXP in Q1 2014 and held it in 5 quarters. The position peaked at $39.5M in Q3 2014. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

Navellier & Associates reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
Navellier & Associates sold 5,450 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $942K.
Navellier & Associates first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q1 2014 and held it in 5 quarters.
Navellier & Associates's SALIX PHARMACEUTICALS LTD DEL position peaked at $39.5M in Q3 2014.
1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Navellier & Associates's 13F filing for Q2 2015, filed 8 Jul 2015.